Sorbic Acid

Sorbic Acid

SCHEMBL1656125

C/C=C/C=C/C(=O)O.NCc1cccc2ccccc12

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 1/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ LMNA P02545 1/20 0.44
▸ RECQL P46063 1/20 0.44
▸ KDM4E B2RXH2 1/20 0.43
▸ P2RX3 P56373 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ MTNR1A P48039 2/20 0.40
▸ CTNNB1 P35222 1/20 0.40
▸ PARP10 Q53GL7 1/20 0.40
▸ SLC1A3 P43003 1/20 0.39
▸ SLC1A2 P43004 1/20 0.39
▸ SLC1A1 P43005 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ ACP3 P15309 1/20 0.39
▸ FTO Q9C0B1 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sorbic Acid SCHEMBL1656128 1.00 TDP1 (0.46) TDP1SMN1; SMN2LMNARECQLKDM4E
Sorbic Acid SCHEMBL1654276 0.81 LOXL2 (0.48) SMN1; SMN2LMNAKDM4ECYP1A2
Sorbic Acid SCHEMBL1654275 0.81 LOXL2 (0.48) SMN1; SMN2LMNAKDM4ECYP1A2
Acetic Acid SCHEMBL31595475 0.80 TDP1 (0.59) TDP1CYP1A2MTNR1ACTNNB1SLC1A3
Oxalic Acid SCHEMBL1922939 0.78 TDP1 (0.61) TDP1KDM4ECYP1A2MTNR1ACTNNB1
Sorbic Acid SCHEMBL1656122 0.76 RAB9A (0.44) SMN1; SMN2LMNARECQLKDM4ECYP1A2
Sorbic Acid SCHEMBL1656121 0.76 RAB9A (0.44) SMN1; SMN2LMNARECQLKDM4ECYP1A2
SCHEMBL110689 0.74 CYP1A2 (0.58) TDP1KDM4ECYP1A2MTNR1AMAPT
SCHEMBL29484446 0.74 CYP1A2 (0.58) TDP1KDM4ECYP1A2MTNR1AMAPT
Ammonia Solution, Strong SCHEMBL5952473 0.74 PARP10 (0.45) TDP1LMNAPARP10SLC1A3SLC1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4239000-A1 COMPOSITION FOR FORMING LOW DIELECTRIC CONSTANT RESIN, LOW DIELECTRIC MEMBER, AND ELECTRONIC DEVICE USING SAME JNC Corporation (JP) 2023-09-06 — — EP disclosed
CN-115989248-A Composition for forming low dielectric constant resin, low dielectric member, and electronic device using the low dielectric member 捷恩智株式会社 2023-04-18 — — CN disclosed
CN-115850580-A Composition for forming low dielectric constant resin and use thereof 捷恩智株式会社 2023-03-28 — — CN disclosed
WO-2022092063-A1 COMPOSITION FOR FORMING LOW DIELECTRIC CONSTANT RESIN, LOW DIELECTRIC MEMBER, AND ELECTRONIC DEVICE USING SAME JNC株式会社 2022-05-05 — — WO disclosed
US-8168734-B2 Lateral alpha-substituted acrylate compound and polymer thereof JNC CORPORATION (JP) 2012-05-01 — — US disclosed
US-20110144293-A1 LATERAL ALPHA-SUBSTITUTED ACRYLATE COMPOUND AND POLYMER THEREOF CHISSO CORPORATION (JP) 2011-06-16 — — US disclosed
US-7919648-B2 Lateral α-substituted acrylate compound and polymer thereof CHISSO CORPORATION (JP) 2011-04-05 — — US disclosed
US-20070134447-A1 Lateral a-substituted acrylate compound and polymer thereof CHISSO CORPORATION 2007-06-14 — — US disclosed
US-7157124-B2 Polymerizable compounds and their polymers CHISSO PETROCHEMICAL CORPORATION (JP) 2007-01-02 — — US disclosed
US-20040222403-A1 Polymerizable compounds and their polymers JNC PETROCHEMICAL CORPORATION (JP) 2004-11-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110144293-A1 LATERAL ALPHA-SUBSTITUTED ACRYLATE COMPOUND AND POLYMER THEREOF LEF1, AFF1, CNKSR1 TDP1 2230/4885SMN1; SMN2 3909/4885LMNA 272/4885
US-20070134447-A1 Lateral a-substituted acrylate compound and polymer thereof AFF1, CNKSR1, LEF1 TDP1 2328/4885SMN1; SMN2 3978/4885LMNA 335/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback